📢 Important Update: The national procurement agreement's metric for DOACs has evolved.
Previously, Edoxaban was the most cost-effective option. Now, with the unexpected early authorisation of generic Apixaban in the UK – a...
Be a part of the medicines team community and join our email list and get blog updates when they happen